TNM clinical staging of prostate cancer: issues and solutions

BJU Int. 2019 Mar;123(3):382-384. doi: 10.1111/bju.14589. Epub 2018 Oct 31.

Authors

Murali Varma¹, Dennis Cochlin², Brett Delahunt³, Howard Kynaston⁴, John Rees², Brian Rous⁵, Krishna Narahari⁴

Affiliations

¹ Department of Pathology, Cardiff and Vale University Heath Board, Cardiff, UK.
² Department of Radiology, Cardiff and Vale University Heath Board, Cardiff, UK.
³ Department of Pathology, Wellington School of Medicine and Health Sciences, Wellington, New Zealand.
⁴ Department of Urology, Cardiff and Vale University Heath Board, Cardiff, UK.
⁵ Department of Pathology, National Cancer Registration and Analysis Service, Cambridge, UK.

PMID: 30315677
DOI: 10.1111/bju.14589

No abstract available

Publication types

Letter

MeSH terms

Humans
Lymphatic Metastasis / pathology*
Male
Neoplasm Staging / methods*
Organ Size
Prostate-Specific Antigen
Prostatic Neoplasms / pathology*
Quality Improvement

Substances

Prostate-Specific Antigen